Campus Location

Abilene Campus (Residential)

Date of Award




Document Type

DNP Project



Degree Name

Doctor of Nursing Practice

Committee Chair or Primary Advisor

Faisal Aboul-Enein

Second Committee Member or Secondary Advisor

Roneisa Matero

Third Committee Member or Committee Reader

Lawrence Santiago


According to a statement from the U.S. Centers for Disease Control and Prevention, between 2000 and 2017, approximately 700,000 people died from drug overdoses in the United States. Approximately 128 persons lose their life each day from an opioid overdose. The data for this study were collected by the vice president of operations at the study site from a preexisting database for 2019 and 2020. The participants were inpatient patients, 18 and older, both male and female, and were from all ethnicities. The study facility was located in Western New York and offered a 30-bed inpatient treatment center with 24-hour care for individuals suffering from opioid use disorder (OUD). The healthcare team consisted of physicians, nurses, behavioral therapists, peer support specialists, and discharge planners. The objective of this descriptive, retrospective project was to investigate the following research questions: Research Question 1: During inpatient MAT treatment for OUD, is there a difference between treatments using buprenorphine/naloxone and those using Vivitrol in the length of stay of patients? Research Question 2: Is there a difference in these two MAT (buprenorphine and Vivitrol) outcomes when controlling for demographic variables of patients with OUD? Research Question 3: Does ethnicity moderate the relationship in MAT types and the length of stay among patients with OUD? The ability to implement the MAT program and experience the benefits is rewarding to the health care team, the patients, and their families. Further education is needed to assist in the fight against this deadly epidemic.

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.